MALAT1 and brain ischemia: Therefore, MALAT1 affects AQP4 expression by competitively binding to miR-145, thereby promoting cerebral ischemia-reperfusion injury, suggesting that MALAT1 may become a new therapeutic target for the treatment of cerebral ischemic stroke.